Filing Details

Accession Number:
0001104659-13-018480
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-07 18:30:57
Reporting Period:
2013-02-25
Filing Date:
2013-03-07
Filing Date Changed:
2013-03-07
Accepted Time:
2013-03-07 18:30:57
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1526119 Verastem, Inc. VSTM Pharmaceutical Preparations (2834) 273269467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291961 H Christoph Westphal C/o Verastem, Inc.
215 First Street, Suite 440
Cambridge MA 02142
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Acquisiton 2013-02-25 100 $9.93 739,095
Common Stock Acquisiton 2013-02-25 259 $9.95 739,354
Common Stock Acquisiton 2013-02-25 41 $9.96 739,395
Common Stock Acquisiton 2013-02-25 200 $9.98 739,595
Common Stock Acquisiton 2013-02-25 200 $9.99 739,795
Common Stock Acquisiton 2013-03-05 800 $9.47 740,595
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 L Direct
No 4 L Direct
No 4 L Direct
No 4 L Direct
No 4 L Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,869,841 Indirect By Longwood Fund, L.P.
Common Stock 125,714 Indirect By the Fountain Irrevocable Trust of 2010
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2012.
  2. Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.50, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2 to this Form 4.
  3. Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose.
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Billionaire Hedge Funds
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!